Celularity Inc. has announced a securities purchase agreement with certain investors for a private placement involving the issuance and sale of 739,286 shares of its Class A common stock at a purchase price of $1.40 per share. In conjunction with this agreement, the company has also revised the exercise price of certain warrants held by these investors to $2.50 per share and extended their expiration date to June 30, 2030. The transaction, expected to close during the week of July 21, 2025, is anticipated to generate gross proceeds of $1,035,000, which the company plans to use for working capital and general corporate purposes.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.